Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial)
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Won Kyung Cho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Radiotherapy, Intensity-Modulated, Chemoradiotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MOHW, Ministry of Health and Welfare.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: For patients with high-risk factors such as pelvic lymph node metastasis, positive surgical margins, or parametrial involvement, concurrent chemoradiotherapy (CCRT) with whole-pelvic radiotherapy significantly improves survival outcomes. Hypofractionated radiation therapy, which delivers higher radiation doses over fewer sessions, enhances tumor control but raises concerns about increased normal tissue toxicity. A recent Korean phase II study (POHIM-CCRT) evaluated the safety of hypofractionated intensity-modulated radiation therapy (IMRT), delivering 40 Gy in 16 fractions with weekly cisplatin following radical surgery. The results showed minimal acute toxicity. Based on these findings, the present study was designed to assess the oncologic efficacy of hypofractionated CCRT compared to conventional treatment strategies in high-risk cervical cancer patients after radical surgery. METHODS: The POHIM-P3 trial is a phase 3, randomized, multicenter study designed for women with cervical cancer requiring adjuvant CCRT after radical hysterectomy. Participants in the experimental arm receive hypofractionated IMRT to whole pelvis, delivering a total dose of 40 Gy in 16 fractions, and the control arm receive conventional radiotherapy with a total dose of 45-50.4 Gy in 25-28 fractions in combination with weekly cisplatin. The primary endpoint of the study is the 3-year disease-free survival and the secondary endpoints included acute and late side-effects, local control rates, and overall survival rates. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06509724.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. wonro.park@samsung.com.
- Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
- Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.
ORCID-Profile: Won Kyung Cho, Won Park, Jong Hoon Lee, Hyun-Cheol Kang, Meesun Yoon, Keun-Yong Eom, Yeon-Sil Kim, Sangjoon Park, Young Seok Kim, Yeon Joo Kim, Euncheol Choi, Dong-Yun Kim
Förderung
- MOHW
- Ministry of Health and Welfare
Zitieren
APA
Cho, W. K., Park, W., Lee, J. H., Kang, H. C., Yoon, M., Eom, K. Y., Kim, Y. S., Park, S., Kim, Y. S., Kim, Y. J., Choi, E., & Kim, D. Y. (2026). Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial). Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e4
Vancouver
Cho WK, Park W, Lee JH, Kang HC, Yoon M, Eom KY, et al. Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial). Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e4
BibTeX
@article{Cho2026,
author = {Cho, Won Kyung and Park, Won and Lee, Jong Hoon and Kang, Hyun-Cheol and Yoon, Meesun and Eom, Keun-Yong and Kim, Yeon-Sil and Park, Sangjoon and Kim, Young Seok and Kim, Yeon Joo and Choi, Euncheol and Kim, Dong-Yun},
title = {Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial)},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e4}
}
EUVIMED